Showing results (61-70 of 159) with videos related to
Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 21, 2019
Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?Sima L Sharara, Joe Amoah, Zoi D Pana, et al.Journal of Clinical Microbiology|September 8, 2017
Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool SpecimensPatricia J Simner, Margret Oethinger, Kathleen A Stellrecht, et al.The Journal of Antimicrobial Chemotherapy|April 2, 2024
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passageAliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.Infectious Diseases (London, England)|March 5, 2025
Comparison of the <i>in vivo</i> efficacy and resistance development potential between cefiderocol and ceftolozane/tazobactam human simulated exposures against <i>Pseudomonas aeruginosa in</i> 72-hour murine thigh infection modelAliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.Antimicrobial Agents and Chemotherapy|May 30, 2019
The Likelihood of Developing a Carbapenem-Resistant <i>Enterobacteriaceae</i> Infection during a Hospital StayPranita D Tamma, Abida Kazmi, Yehudit Bergman, et al.Journal of Clinical Microbiology|May 14, 2025
Development of disk diffusion susceptibility test methods for <i>Aerococcus</i> spp. and updates to Clinical and Laboratory Standards Institute MIC breakpointsRichard Maynard, Carmila Manuel, Synthia Simpkins, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 11, 2021
Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimensRebecca Yee, Stefanie Fisher, Yehudit Bergman, et al.Open Forum Infectious Diseases|June 8, 2018
Using Patient Risk Factors to Identify Whether Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections Are Caused by Carbapenemase-Producing OrganismsPatricia J Simner, Katherine E Goodman, Karen C Carroll, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2016
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae BacteremiaPranita D Tamma, Katherine E Goodman, Anthony D Harris, et al.Journal of Clinical Microbiology|October 4, 2023
Updating breakpoints in the United States: a summary from the ASM Clinical Microbiology Open 2022Jean B Patel, Kevin Alby, Romney Humphries, et al.Pageof 16